We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$791M
AUM Growth
+$70.8M
Cap. Flow
+$67.6M
Cap. Flow %
8.55%
Top 10 Hldgs %
17.24%
Holding
1,106
New
68
Increased
214
Reduced
81
Closed
742

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 11.98%
3 Consumer Discretionary 11.21%
4 Financials 10.27%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
251
DELISTED
Clovis Oncology, Inc.
CLVS
$1.48M 0.19%
42,347
+15,062
+55% +$971K
DUK icon
252
Duke Energy
DUK
$97.3B
$1.47M 0.19%
20,575
+20,467
+18,951% +$1.44M
CVS icon
253
CVS Health
CVS
$122B
$1.44M 0.18%
14,774
+14,729
+32,731% +$1.44M
BIIB icon
254
Biogen
BIIB
$30.7B
$1.44M 0.18%
4,708
-8,451
-64% -$2.43M
QCOM icon
255
Qualcomm
QCOM
$176B
$1.43M 0.18%
28,668
-22,747
-44% -$1.21M
V icon
256
Visa
V
$677B
$1.43M 0.18%
18,469
+18,414
+33,480% +$1.43M
JPM icon
257
JPMorgan Chase
JPM
$950B
$1.43M 0.18%
21,678
+15,180
+234% +$988K
MSGN
258
DELISTED
MSG Networks Inc.
MSGN
$1.43M 0.18%
+68,809
New +$1.4M
ACHN
259
DELISTED
Achillion Pharmaceuticals
ACHN
$1.41M 0.18%
+130,685
New +$1.19M
MDT icon
260
Medtronic
MDT
$112B
$1.41M 0.18%
18,286
-10,002
-35% -$753K
EMC
261
DELISTED
EMC CORPORATION
EMC
$1.41M 0.18%
54,744
+50,349
+1,146% +$1.31M
LLY icon
262
Eli Lilly
LLY
$1.06T
$1.4M 0.18%
16,658
-8,287
-33% -$688K
EQIX icon
263
Equinix
EQIX
$103B
$1.4M 0.18%
4,634
-3,266
-41% -$954K
GM icon
264
General Motors
GM
$76.8B
$1.4M 0.18%
41,063
-54,395
-57% -$1.89M
AYR
265
DELISTED
Aircastle Ltd
AYR
$1.39M 0.18%
66,751
+45,486
+214% +$959K
SKX
266
DELISTED
Skechers
SKX
$1.38M 0.17%
45,624
+1,917
+4% +$64.1K
BBWI icon
267
Bath & Body Works
BBWI
$4.1B
$1.38M 0.17%
17,765
-13,290
-43% -$1.03M
IBKR icon
268
Interactive Brokers
IBKR
$39.8B
$1.37M 0.17%
125,592
-82,852
-40% -$865K
AMKR icon
269
Amkor Technology
AMKR
$13.7B
$1.37M 0.17%
224,993
+106,445
+90% +$644K
META icon
270
Meta Platforms (Facebook)
META
$1.51T
$1.37M 0.17%
13,070
-9,254
-41% -$951K
STZ icon
271
Constellation Brands
STZ
$23.2B
$1.37M 0.17%
9,602
-6,110
-39% -$841K
LBTYK icon
272
Liberty Global Class C
LBTYK
$3.49B
$1.36M 0.17%
+38,479
New +$1.39M
ATRC icon
273
AtriCure
ATRC
$2.11B
$1.36M 0.17%
60,615
-17,851
-23% -$368K
ENDP
274
DELISTED
Endo International plc
ENDP
$1.35M 0.17%
22,094
+22,043
+43,222% +$1.34M
FPF
275
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$1.34M 0.17%
63,080
-122,384
-66% -$2.64M

Similar funds

Vident Investment Advisory's Q4 2015 Portfolio in Review

As of Q4 2015, Vident Investment Advisory held 1,106 positions worth $791M, up 9.8% from $720M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Vident Investment Advisory deployed $67.6M of net new capital in Q4 2015, opening 68 new positions and adding to 214 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 450,105 shares worth $91.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $5.78M trimmed.

  • Vident Investment Advisory's largest Q4 2015 buy was State Street SPDR S&P 500 ETF Trust: 450,105 shares worth $91.8M.
  • Vident Investment Advisory added most to D.R. Horton in Q4 2015, an estimated $3.39M increase.
  • Vident Investment Advisory's biggest Q4 2015 reduction was Apple, cutting an estimated $5.78M.
  • Vident Investment Advisory fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q4 2015, selling an estimated $7.25M.
  • Vident Investment Advisory's ten largest holdings make up 17% of its $791M portfolio in Q4 2015.
  • Vident Investment Advisory opened 68 new positions and closed 742 in Q4 2015.
  • Vident Investment Advisory's portfolio value rose 9.8% quarter-over-quarter to $791M.

Based on Vident Investment Advisory's 13F filing for Q4 2015, filed 17 Feb 2016.